Leukemia: overview, types, causes, diagnosis, and treatment

Classification and main characteristics

Doctors classify leukemia by the speed of onset and the type of white cell involved. Two major clinical divisions are:

• Acute leukemias: rapid onset, immature cells (blasts) accumulate quickly and require prompt treatment.
• Chronic leukemias: slower progression, more mature-appearing cells, may be monitored before therapy is needed.

Another axis of classification separates lymphoid (affecting lymphocyte precursors) from myeloid (affecting granulocyte or red/platelet precursors) lineages. Combining these distinctions yields common categories such as acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia.

Causes and risk factors

Leukemia arises from genetic changes in blood-forming cells that alter growth control. Known risk factors include prior exposure to high-dose ionizing radiation, certain chemical exposures, some chemotherapy agents, and inherited genetic predispositions. Many cases, however, occur with no identifiable cause. Research continues to clarify how environmental and hereditary elements interact to trigger malignant transformation.

Diagnosis and management

Diagnosis typically begins with blood count abnormalities and is confirmed by bone marrow examination and specialised laboratory tests, including cell morphology, immunophenotyping and genetic or molecular studies. For an overview of diagnostic approaches see diagnostic resources. Treatment options depend on the subtype and patient factors and can include chemotherapy, targeted therapies that act on specific molecular changes, immunotherapies, and hematopoietic stem cell transplantation. Supportive care (transfusions, antibiotics) is critical during many treatment phases.

History, epidemiology and prognosis

Descriptions of leukemia date back more than a century, and advances in microscopy, chemotherapy and molecular biology have transformed outcomes for many patients. Incidence patterns show that most cases occur in adults, though certain subtypes are more common in children. Prognosis ranges from curable with current therapies to chronic control or, in some cases, limited survival without effective treatment. Individual prognosis depends on leukemia type, genetic features of the cancer, and response to therapy.

Notable distinctions and further resources

Leukemia is part of the broader group called hematologic malignancies or blood cancers. It differs from lymphomas mainly by where malignant cells are primarily located (blood and marrow versus lymph nodes) and by clinical behavior. For patient-oriented information and guidance on care pathways see additional resources. Ongoing research continues to improve targeted drugs, immunotherapies and transplant techniques, offering better outcomes for many patients.